{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:45:51Z","timestamp":1787067951142,"version":"build-2736575974"},"reference-count":73,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"NIH NCI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jaad.2025.02.021","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T19:00:34Z","timestamp":1739473234000},"page":"1351-1359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Palliative oncodermatology: Management of malignancy-related cutaneous symptoms in the palliative care setting"],"prefix":"10.1016","volume":"92","author":[{"given":"Yasmine","family":"Oprea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alana","family":"Deutsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"McLellan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Markova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jaad.2025.02.021_bib1","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra1404684","article-title":"Palliative care for the seriously ill","volume":"373","author":"Kelley","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jaad.2025.02.021_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0885-3924(02)00440-2","article-title":"Palliative care: the world health organization's global perspective","volume":"24","author":"Sepulveda","year":"2002","journal-title":"J Pain Symptom Manage"},{"issue":"8","key":"10.1016\/j.jaad.2025.02.021_bib3","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa1000678","article-title":"Early palliative care for patients with metastatic non-small-cell lung cancer","volume":"363","author":"Temel","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jaad.2025.02.021_bib4","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/s12885-021-08072-4","article-title":"Patient-identified early clinical warning signs of nodular melanoma: a qualitative study","volume":"21","author":"Coroiu","year":"2021","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.jaad.2025.02.021_bib5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/cncr.11513","article-title":"Symptoms and signs of primary melanoma: important indicators of Breslow depth","volume":"98","author":"Negin","year":"2003","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.jaad.2025.02.021_bib6","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1001\/jamadermatol.2014.895","article-title":"Association of pain and itch with depth of invasion and inflammatory cell constitution in skin cancer: results of a large clinicopathologic study","volume":"150","author":"Yosipovitch","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2025.02.021_bib8","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/pon.6184","article-title":"Psychological and behavioral symptoms in patients with melanoma: a systematic review and meta-analysis","volume":"32","author":"Danielsen","year":"2023","journal-title":"Psychooncology"},{"issue":"9-10","key":"10.1016\/j.jaad.2025.02.021_bib10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00508-017-1194-y","article-title":"Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis","volume":"129","author":"Pabinger","year":"2017","journal-title":"Wien Klin Wochenschr"},{"issue":"1","key":"10.1016\/j.jaad.2025.02.021_bib11","article-title":"Topical tranexamic acid for prophylaxis of bleeding","volume":"143","author":"Ausen","year":"2023","journal-title":"Tidsskr Nor Laegeforen"},{"key":"10.1016\/j.jaad.2025.02.021_bib12","article-title":"Topical silver nitrate for the management of hemostasis: a review of clinical effectiveness, cost-effectiveness, and guidelines","author":"Ho","year":"2018","journal-title":"CADTH Rapid Response Reports"},{"issue":"8","key":"10.1016\/j.jaad.2025.02.021_bib13","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.sdentj.2022.11.007","article-title":"Gelatin-based hemostatic agents for medical and dental application at a glance: a narrative literature review","volume":"34","author":"Irfan","year":"2022","journal-title":"Saudi Dent J"},{"key":"10.1016\/j.jaad.2025.02.021_bib19","series-title":"Local Wound Care for Dermatologists. Updates in Clinical Dermatology","article-title":"Comprehensive wound care for malignant wounds","author":"Corbett","year":"2020"},{"issue":"6","key":"10.1016\/j.jaad.2025.02.021_bib17","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.3904\/kjim.2018.162","article-title":"Neuropathic cancer pain: prevalence, pathophysiology, and management","volume":"33","author":"Yoon","year":"2018","journal-title":"Korean J Intern Med"},{"issue":"4 Suppl 1","key":"10.1016\/j.jaad.2025.02.021_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/00325481.2013.1110567111","article-title":"Topical therapies in the management of chronic pain","volume":"125","author":"Stanos","year":"2013","journal-title":"Postgrad Med J"},{"issue":"5","key":"10.1016\/j.jaad.2025.02.021_bib20","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/MJT.0b013e3182459abd","article-title":"Topical nonsteroidal anti-inflammatory drugs: the importance of drug, delivery, and therapeutic outcome","volume":"22","author":"Barkin","year":"2015","journal-title":"Am J Ther"},{"key":"10.1016\/j.jaad.2025.02.021_bib21","series-title":"Regional Anesthetic Blocks. StatPearls","author":"Folino","year":"2023"},{"key":"10.1016\/j.jaad.2025.02.021_bib26","first-page":"e6","article-title":"Hypochlorous acid as a potential wound care agent: Part II. Stabilized hypochlorous acid: its role in decreasing tissue bacterial bioburden and overcoming the inhibition of infection on wound healing","volume":"6","author":"Robson","year":"2007","journal-title":"J Burns Wounds"},{"issue":"3","key":"10.1016\/j.jaad.2025.02.021_bib27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4103\/ijps.IJPS_245_16","article-title":"Acetic acid dressings: finding the Holy Grail for infected wound management","volume":"50","author":"Agrawal","year":"2017","journal-title":"Indian J Plast Surg"},{"key":"10.1016\/j.jaad.2025.02.021_bib28","series-title":"Mupirocin. StatPearls","author":"Erwin","year":"2024"},{"issue":"9","key":"10.1016\/j.jaad.2025.02.021_bib29","first-page":"7615","article-title":"Management of malignant cutaneous wounds in oncologic patients","volume":"30","author":"Starace","year":"2022","journal-title":"Support Care Cancer"},{"issue":"2","key":"10.1016\/j.jaad.2025.02.021_bib30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4103\/ijd.IJD_99_18","article-title":"Topical antibacterials in Dermatology","volume":"66","author":"Bandyopadhyay","year":"2021","journal-title":"Indian J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2025.02.021_bib33","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/0885-3924(95)00164-6","article-title":"The effect of topical 0.75% metronidazole gel on malodorous cutaneous ulcers","volume":"11","author":"Finlay","year":"1996","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"10.1016\/j.jaad.2025.02.021_bib31","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/bmjspcare-2016-001166","article-title":"Improving malodour management in advanced cancer: a 10-year retrospective study of topical, oral and maintenance metronidazole","volume":"7","author":"George","year":"2017","journal-title":"BMJ Support Palliat Care"},{"issue":"8","key":"10.1016\/j.jaad.2025.02.021_bib32","article-title":"Systemic antibiotics for treating malignant wounds","volume":"8","author":"Ramasubbu","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.jaad.2025.02.021_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000324923","article-title":"Fungating wounds - multidimensional challenge in palliative care","volume":"6","author":"Merz","year":"2011","journal-title":"Breast Care (Basel)"},{"issue":"4","key":"10.1016\/j.jaad.2025.02.021_bib9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.25100\/cm.v44i4.1504","article-title":"Anemia and transfusion of red blood cells","volume":"44","author":"Cortes Buelvas","year":"2013","journal-title":"Colomb M\u00e9d"},{"key":"10.1016\/j.jaad.2025.02.021_bib14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.tmrv.2018.02.003","article-title":"The efficacy and safety of topical tranexamic acid: a systematic review and meta-analysis","volume":"32","author":"Montroy","year":"2018","journal-title":"Transfus Med Rev"},{"issue":"12","key":"10.1016\/j.jaad.2025.02.021_bib15","first-page":"32","article-title":"A comparison of ferric subsulfate solution, silver nitrate, and aluminum chloride for pain assessment, time to hemostasis, and cosmesis in acrochordon snip excision","volume":"13","author":"Coakley","year":"2020","journal-title":"J Clin Aesthet Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2025.02.021_bib16","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jaad.2021.11.026","article-title":"Quality of life before and after treatment of cutaneous metastases with palliative radiotherapy","volume":"87","author":"Reingold","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.02.021_bib22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4103\/0019-5154.62742","article-title":"Malignant melanoma presenting as multiple discharging sinuses","volume":"55","author":"Bhagwat","year":"2010","journal-title":"Indian J Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2025.02.021_bib23","doi-asserted-by":"crossref","first-page":"325","DOI":"10.12968\/jowc.2009.18.8.43631","article-title":"Malignant fungating wounds: key symptoms and psychosocial issues","volume":"18","author":"Alexander","year":"2009","journal-title":"J Wound Care"},{"issue":"3","key":"10.1016\/j.jaad.2025.02.021_bib24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0022034509359125","article-title":"Factors affecting wound healing","volume":"89","author":"Guo","year":"2010","journal-title":"J Dent Res"},{"issue":"Suppl 3","key":"10.1016\/j.jaad.2025.02.021_bib34","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.1093\/cid\/ciz004","article-title":"Current treatment options for acute skin and skin-structure infections","volume":"68","author":"Golan","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2025.02.021_bib39","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/978-3-662-44605-8_18","article-title":"Current topical and systemic therapies for itch","volume":"226","author":"Leslie","year":"2015","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.jaad.2025.02.021_bib40","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/978-3-662-44605-8_15","article-title":"Antihistamines and itch","volume":"226","author":"Thurmond","year":"2015","journal-title":"Handb Exp Pharmacol"},{"issue":"6","key":"10.1016\/j.jaad.2025.02.021_bib41","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jaad.2017.08.025","article-title":"Use of oral antidepressants in patients with chronic pruritus: a systematic review","volume":"77","author":"Kouwenhoven","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.02.021_bib48","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4790810","article-title":"Aprepitant for the treatment of chronic refractory pruritus","volume":"2017","author":"He","year":"2017","journal-title":"BioMed Res Int"},{"issue":"3","key":"10.1016\/j.jaad.2025.02.021_bib49","article-title":"Dupilumab for cancer-associated refractory pruritus","volume":"2","author":"Talmon","year":"2023","journal-title":"J Allergy Clin Immunol Glob"},{"issue":"6","key":"10.1016\/j.jaad.2025.02.021_bib52","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jpainsymman.2010.09.015","article-title":"Subcutaneous lymphatic drainage (lymphcentesis) for palliation of severe refractory lymphedema in cancer patients","volume":"41","author":"Jacobsen","year":"2011","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"10.1016\/j.jaad.2025.02.021_bib54","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3810\/pgm.2005.01.1577","article-title":"Exfoliative dermatitis. Erythroderma can be a sign of a significant underlying disorder","volume":"117","author":"Jaffer","year":"2005","journal-title":"Postgrad Med J"},{"issue":"15","key":"10.1016\/j.jaad.2025.02.021_bib58","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1001\/jama.2019.3504","article-title":"Effect of doxepin mouthwash or diphenhydramine-lidocaine-antacid mouthwash vs placebo on radiotherapy-related oral mucositis pain: the alliance A221304 randomized clinical trial","volume":"321","author":"Sio","year":"2019","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jaad.2025.02.021_bib59","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/000163598422893","article-title":"Aqueous hydrocortisone mouthwash solution: clinical evaluation","volume":"56","author":"Holbrook","year":"1998","journal-title":"Acta Odontol Scand"},{"issue":"6","key":"10.1016\/j.jaad.2025.02.021_bib65","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.amjms.2016.10.003","article-title":"Recurrent malignancy-associated atypical neutrophilic dermatosis with noninfectious shock","volume":"354","author":"Kinser","year":"2017","journal-title":"Am J Med Sci"},{"issue":"1","key":"10.1016\/j.jaad.2025.02.021_bib66","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/jamadermatol.2018.3890","article-title":"Clinical features of neutrophilic dermatosis variants resembling necrotizing fasciitis","volume":"155","author":"Sanchez","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2025.02.021_bib67","article-title":"Refractory sweet syndrome treated with anakinra","volume":"11","author":"Shahid","year":"2019","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.jaad.2025.02.021_bib68","doi-asserted-by":"crossref","first-page":"20","DOI":"10.47936\/encephalitis.2020.00059","article-title":"Refractory neuro-Sweet disease successfully treated with tocilizumab and mycophenolate mofetil","volume":"1","author":"Hwang","year":"2021","journal-title":"Encephalitis"},{"issue":"2","key":"10.1016\/j.jaad.2025.02.021_bib69","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000326112","article-title":"Efficacy of anti-interleukin-1 receptor antagonist anakinra (Kineret(R)) in a case of refractory sweet's syndrome","volume":"222","author":"Kluger","year":"2011","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.jaad.2025.02.021_bib72","first-page":"1073","article-title":"How can we effectively address the paraneoplastic dermatomyositis: diagnosis, risk factors and treatment options","volume":"22","author":"Zerdes","year":"2017","journal-title":"J BUON"},{"issue":"34","key":"10.1016\/j.jaad.2025.02.021_bib73","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000021733","article-title":"Malignancy in dermatomyositis: a retrospective paired case-control study of 202 patients from Central China","volume":"99","author":"Chang","year":"2020","journal-title":"Medicine (Baltim)"},{"issue":"6","key":"10.1016\/j.jaad.2025.02.021_bib35","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1529-8019.2010.01366.x","article-title":"Chronic pruritus: a paraneoplastic sign","volume":"23","author":"Yosipovitch","year":"2010","journal-title":"Dermatol Ther"},{"issue":"3","key":"10.1016\/j.jaad.2025.02.021_bib36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.det.2018.02.011","article-title":"Pruritus in cutaneous T-cell lymphoma and its management","volume":"36","author":"Serrano","year":"2018","journal-title":"Dermatol Clin"},{"issue":"10","key":"10.1016\/j.jaad.2025.02.021_bib37","first-page":"3897","article-title":"Pruritus in patients with solid tumors: an overlooked supportive care need","volume":"27","author":"Vallely","year":"2019","journal-title":"Support Care Cancer"},{"issue":"3","key":"10.1016\/j.jaad.2025.02.021_bib38","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2133.1993.tb11868.x","article-title":"Aquagenic pruritus and acute lymphoblastic leukaemia","volume":"129","author":"Ratnaval","year":"1993","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.02.021_bib42","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.jpainsymman.2003.05.004","article-title":"Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial","volume":"26","author":"Zylicz","year":"2003","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"10.1016\/j.jaad.2025.02.021_bib43","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s13256-017-1437-6","article-title":"Treatment of pruritus in a palliative care patient with low-dose paroxetine: a case report","volume":"11","author":"Kraut","year":"2017","journal-title":"J Med Case Rep"},{"issue":"6","key":"10.1016\/j.jaad.2025.02.021_bib44","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s40265-021-01478-1","article-title":"Neurokinin 1 receptor antagonists for pruritus","volume":"81","author":"Alam","year":"2021","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.jaad.2025.02.021_bib45","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/1049909112445464","article-title":"Gabapentin for pruritus in palliative care","volume":"30","author":"Anand","year":"2013","journal-title":"Am J Hosp Palliat Care"},{"issue":"8","key":"10.1016\/j.jaad.2025.02.021_bib46","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1468-3083.2009.03129.x","article-title":"Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study","volume":"23","author":"Malekzad","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2025.02.021_bib47","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/j.jaad.2018.05.027","article-title":"Dose escalation of doxepin for intractable pruritus","volume":"79","author":"Beck","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2025.02.021_bib50","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijwd.2019.02.004","article-title":"Art of prevention: the importance of bath time and avoiding extended exposure to irritating and allergenic chemicals","volume":"5","author":"Novosel","year":"2019","journal-title":"Int J Womens Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2025.02.021_bib51","doi-asserted-by":"crossref","first-page":"691","DOI":"10.46747\/cfp.6910691","article-title":"Cancer-related lymphedema","volume":"69","author":"Chaput","year":"2023","journal-title":"Can Fam Physician"},{"issue":"1","key":"10.1016\/j.jaad.2025.02.021_bib53","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4103\/ijd.IJD_189_18","article-title":"Paraneoplastic erythroderma as a protean manifestation of adenocarcinoma prostate","volume":"65","author":"Danny","year":"2020","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.jaad.2025.02.021_bib55","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/351065","article-title":"Breast cancer presenting as paraneoplastic erythroderma: an extremely rare case","volume":"2014","author":"Protopsaltis","year":"2014","journal-title":"Case Rep Med"},{"key":"10.1016\/j.jaad.2025.02.021_bib56","article-title":"Tocilizumab controls paraneoplastic inflammatory syndrome but does not suppress tumor growth of angiomatoid fibrous histiocytoma","volume":"16","author":"Sabe","year":"2021","journal-title":"Case Rep Oncol Med"},{"key":"10.1016\/j.jaad.2025.02.021_bib57","series-title":"Paraneoplastic Pemphigus. StatPearls","author":"Kappius","year":"2024"},{"issue":"3","key":"10.1016\/j.jaad.2025.02.021_bib60","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/cncr.27772","article-title":"Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States","volume":"119","author":"Khorana","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2025.02.021_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1199195","article-title":"Intravenous immunoglobulin is safe and effective in controlling pre-existing paraneoplastic neuromuscular diseases in cancer patients treated with immune checkpoint inhibitors: two case reports and literature review","volume":"13","author":"Xiong","year":"2023","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.jaad.2025.02.021_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-017-8662-z","article-title":"Pemphigus: a comprehensive review on pathogenesis, clinical presentation and novel therapeutic approaches","volume":"54","author":"Pollmann","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"issue":"10","key":"10.1016\/j.jaad.2025.02.021_bib63","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.autrev.2018.04.008","article-title":"Paraneoplastic autoimmune multiorgan syndrome (PAMS): beyond the single phenotype of paraneoplastic pemphigus","volume":"17","author":"Amber","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaad.2025.02.021_bib64","series-title":"Sweet Syndrome. StatPearls","author":"Vashisht","year":"2024"},{"issue":"1","key":"10.1016\/j.jaad.2025.02.021_bib70","first-page":"57","article-title":"Paraneoplastic dermatomyositis with cutaneous and myopathic disease responsive to adrenocorticotropic hormone therapy","volume":"10","author":"Wolff","year":"2017","journal-title":"J Clin Aesthet Dermatol"},{"issue":"21","key":"10.1016\/j.jaad.2025.02.021_bib71","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","article-title":"Polymyositis, dermatomyositis and inclusion-body myositis","volume":"325","author":"Dalakas","year":"1991","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jaad.2025.02.021_bib74","doi-asserted-by":"crossref","first-page":"165","DOI":"10.21037\/apm.2016.11.10","article-title":"Palliative radiotherapy for skin malignancies","volume":"6","author":"Vuong","year":"2017","journal-title":"Ann Palliat Med"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225002609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225002609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T17:04:01Z","timestamp":1777568641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962225002609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":73,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0190962225002609"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.02.021","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Palliative oncodermatology: Management of malignancy-related cutaneous symptoms in the palliative care setting","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}